Reported By: | Edited By: DNA Web Team |Source: DNA webdesk |As a lot as this level: Feb 16, 2022, 12: 17 AM IST
The stock market investors is a sage of usaand downs. While some investors stumble on immediate timeframe good points, the bulk of investors are other folks that glance at stocks which might be reasonably less gorgeous nonetheless provides sturdy enhance in the long timeframe. Such investors can stop up taking advantage of bumper returns on multibagger stocks. This day, we are capable of order you about one such stock which grew to change into Rs 1 lakh into Rs 46 lakh in a pretty solid investment length of 13 years.
Funding of Rs 1 lakh becomes Rs 46 lakh
The half we are talking about is named Aurobindo Pharma Ltd (NSE: AUROPHARMA). The stock stands at Rs 691.40 on February 13, 2022. Examine this to Rs 14.98, which modified into as soon as the stock’s tag aid on February 13, 2009. This kind that the multibagger stock gave a solid return of 4615.49% over the length.
While the stock right this moment stands at a solid compose at Rs 691.40, it has long previous even greater in the final year, reaching as excessive as Rs 1047.95 aid on Could presumably also fair 10, 2021.
READ | Multibagger penny stocks: 2000% bumper return on investment in 1 year, here’s how
What does the firm stop?
An Indian pharmaceutical firm, Aurobindo Pharma Restricted manufactures generic pharmaceuticals and energetic pharmaceutical blueprint (APIs). Its merchandise encompass antibiotics, anti-retrovirals, anti-allergics, gastroenterologicals, cardiovascular and central anxious procedure merchandise. Headquartered in HITEC City, Hyderabad, it’s merchandise are aged in more than 125 countries spherical the enviornment. The likes of AstraZeneca and Pfizer are marketing companions of Aurobindo Pharma Ltd.
